Logo (WIPO, 01.11.2007)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke wurde als Bildmarke am 01.11.2007 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Kreise #Linien, Bänder #Kreise mit anderen figurativen Elementen #Kreise mit dunklen Flächen oder Teilen von Flächen #Gekrümmte Linien oder Bänder (außer A 26.11.13)
| Markenform | Bildmarke |
| Aktenzeichen | 972485 |
| Länder | 
|
| Basismarke |
Nr. ,
16. Februar 2025
|
| Anmeldedatum | 01. November 2007 |
| Ablaufdatum | 01. November 2027 |
Markeninhaber
2525 Dupont Drive
Irvine, CA 92612
US
Irvine, CA 92612
US
Waren und Dienstleistungen
05
Pharmaceutical products for use in the treatment of
cardiovascular diseases and disorders, central nervous
system and neurological diseases and disorders, urological
diseases and disorders, gastrointestinal diseases and
disorders, musculoskeletal diseases and disorders, migraines
and headaches, pain, hypertension, inflammation and
inflammatory diseases and disorders, metabolic diseases and
disorders, respiratory and infectious diseases and
disorders, immunological, bacterial, viral and fungal
diseases and disorders, psychiatric diseases and disorders,
asthma, allergies, diabetes, obesity, stroke, erectile and
sexual dysfunction, and hemolytic diseases and disorders;
pharmaceutical preparations, namely, cholesterol
preparations, osteoporosis preparations, oncological
preparations, dermatological preparations, ophthalmologic
preparations, smoking cessation preparations, tissue and
skin repair preparations and gynecological preparations;
pre-filled drug cartridges, sold with inhalers, which
deliver medication in liquid form via the pulmonary route,
either directly to the lungs or for absorption and delivery
in systemic circulation for use in the treatment of
cardiovascular diseases and disorders, central nervous
system and neurological diseases and disorders, urological
diseases and disorders, gastrointestinal diseases and
disorders, musculoskeletal diseases and disorders, migraines
and headaches, pain, hypertension, inflammation and
inflammatory diseases and disorders, metabolic diseases and
disorders, respiratory and infectious diseases and
disorders, immunological, bacterial, viral and fungal
diseases and disorders, psychiatric diseases and disorders,
asthma, allergies, diabetes, obesity, stroke, erectile and
sexual dysfunction, and hemolytic diseases and disorders;
pre-filled drug cartridges, sold with inhalers, which
deliver medication in liquid form via the pulmonary route,
either directly to the lungs or for absorption and delivery
in systemic circulation for use in the delivery of
cholesterol preparations, osteoporosis preparations,
oncological preparations, dermatological preparations,
ophthalmologic preparations, smoking cessation preparations,
tissue and skin repair preparations and gynecological
preparations.
42
Pharmaceutical research and development; research and
development of pharmaceutical preparations for the treatment
of cardiovascular diseases and disorders, central nervous
system and neurological diseases and disorders, urological
diseases and disorders, gastrointestinal diseases and
disorders, musculoskeletal diseases and disorders, migraines
and headaches, pain, hypertension, inflammation and
inflammatory diseases and disorders, metabolic diseases and
disorders, respiratory and infectious diseases and
disorders, immunological, bacterial, viral and fungal
diseases and disorders, psychiatric diseases and disorders,
asthma, allergies, diabetes, obesity, stroke, erectile and
sexual dysfunction, and hemolytic diseases and disorders;
research and development of pharmaceutical preparations,
namely, cholesterol preparations, osteoporosis preparations,
oncological preparations, dermatological preparations,
ophthalmologic preparations, smoking cessation preparations,
tissue and skin repair preparations and gynecological
preparations; research and development of drug delivery
devices, both with and without pre-filled drug cartridges,
for delivery of medication via the pulmonary route; medical
and scientific research, namely conducting clinical trials.
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 01. November 2017 | 2017/45 Gaz | Verlängerung | |
| 06. April 2012 | 2013/7 Gaz | US | RAW: Partial Ceasing Effect |
| 20. Juli 2009 | 2009/30 Gaz | EM | RAW: Protection Granted |
| 19. November 2008 | 2008/48 Gaz | US | RAW: Division or Merger of Basic Registration |
| 01. November 2007 | 2008/34 Gaz | US | Eintragung |
ID: 14972485